Antimicrobial proteins (AMP) are small endogenous proteins which are capable of rapidly inactivating microorganisms at low micro- and nanomolar concentrations. Their significance in host defense is reflected by their wide distribution in nature. Several AMP have been isolated from human skin, and there is increasing evidence that AMP may play an important role in cutaneous defense. One important human AMP class comprises several antimicrobial members of the RNase A superfamily. Of these, two members, RNase 7 and RNase 5, have been implicated in cutaneous defense. This review gives an overview about our current knowledge on the potential role of RNase 7 and RNase 5 in protecting human skin from infection.

Keywords:
Antimicrobial proteins, Antimicrobial peptides, Antimicrobial ribonucleases, Cutaneous defense
1.
Harder J: Antimicrobial peptides: ancient molecules as modern therapeutics? Expert Rev Dermatol 2008;3:1–5.
2.
Bosch TC, Augustin R, Anton-Erxleben F, Fraune S, Hemmrich G, Zill H, Rosenstiel P, Jacobs G, Schreiber S, Leippe M, Stanisak M, Grotzinger J, Jung S, Podschun R, Bartels J, Harder J, Schröder JM: Uncovering the evolutionary history of innate immunity: the simple metazoan hydra uses epithelial cells for host defence. Dev Comp Immunol 2009;33:559–569.
3.
Fraune S, Augustin R, Anton-Erxleben F, Wittlieb J, Gelhaus C, Klimovich VB, Samoilovich MP, Bosch TC: In an early branching metazoan, bacterial colonization of the embryo is controlled by maternal antimicrobial peptides. Proc Natl Acad Sci USA 2010;107:18067–18072.
4.
Leippe M, Herbst R: Ancient weapons for attack and defense: the pore-forming polypeptides of pathogenic enteric and free-living amoeboid protozoa. J Eukaryot Microbiol 2004;51:516–521.
5.
Sahl HG: Gene-encoded antibiotics made in bacteria. Ciba Found Symp 1994;186:27–53.
6.
Harder J, Gläser R, Schröder JM: Human antimicrobial proteins effectors of innate immunity. J Endotoxin Res 2007;13:317–338.
7.
Wiesner J, Vilcinskas A: Antimicrobial peptides: The ancient arm of the human immune system. Virulence 2010;1:440–464.
8.
Soehnlein O: Direct and alternative antimicrobial mechanisms of neutrophil-derived granule proteins. J Mol Med (Berl) 2009;87:1157–1164.
9.
Bevins CL, Salzman NH: Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis. Nat Rev Microbiol 2011;9:356–368.
10.
Harder J, Gläser R, Schröder JM: The role and potential therapeutical applications of antimicrobial proteins in infectious and inflammatory diseases. Endocr Metab Immune Disord Drug Targets 2007;7:75–82.
11.
Harder J, Schröder JM: Psoriatic scales: a promising source for the isolation of human skin-derived antimicrobial proteins. J Leukoc Biol 2005;77:476–486.
12.
Schröder JM, Harder J: Antimicrobial skin peptides and proteins. Cell Mol Life Sci 2006;63:469–486.
13.
Harder J, Schröder JM: Antimicrobial peptides in human skin. Chem Immunol Allergy 2005;86:22–41.
14.
Schauber J, Gallo RL: Antimicrobial peptides and the skin immune defense system. J Allergy Clin Immunol 2009;124:R13–R18.
15.
Sorrentino S: The eight human ‘canonical’ ribonucleases: molecular diversity, catalytic properties, and special biological actions of the enzyme proteins. FEBS Lett 2010;584:2194–2200.
16.
Cho S, Beintema JJ, Zhang J: The ribonuclease A superfamily of mammals and birds: identifying new members and tracing evolutionary histories. Genomics 2005;85:208–220.
17.
Rosenberg HF: RNase A ribonucleases and host defense: an evolving story. J Leukoc Biol 2008;83:1079–1087.
18.
Boix E, Nogues MV: Mammalian antimicrobial proteins and peptides: overview on the RNase A superfamily members involved in innate host defence. Mol Biosyst 2007;3:317–335.
19.
Zhang J, Dyer KD, Rosenberg HF: RNase 8, a novel RNase A superfamily ribonuclease expressed uniquely in placenta. Nucleic Acids Res 2002;30:1169–1175.
20.
Rudolph B, Podschun R, Sahly H, Schubert S, Schröder JM, Harder J: Identification of RNase 8 as a novel human antimicrobial protein. Antimicrob Agents Chemother 2006;50:3194–3196.
21.
Cheng GZ, Li JY, Li F, Wang HY, Shi GX: Human ribonuclease 9, a member of ribonuclease A superfamily, specifically expressed in epididymis, is a novel sperm-binding protein. Asian J Androl 2009;11:240–251.
22.
Harder J, Schröder JM: RNase 7, a novel innate immune defense antimicrobial protein of healthy human skin. J Biol Chem 2002;277:46779–46784.
23.
Zhang J, Dyer KD, Rosenberg HF: Human RNase 7: a new cationic ribonuclease of the RNase A superfamily. Nucleic Acids Res 2003;31:602–607.
24.
Köten B, Simanski M, Gläser R, Podschun R, Schröder JM, Harder J: RNase 7 contributes to the cutaneous defense against Enterococcus faecium. PLoS One 2009;4:e6424.
25.
Huang YC, Lin YM, Chang TW, Wu SJ, Lee YS, Chang MD, Chen C, Wu SH, Liao YD: The flexible and clustered lysine residues of human ribonuclease 7 are critical for membrane permeability and antimicrobial activity. J Biol Chem 2007;282:4626–4633.
26.
Venge P, Bystrom J, Carlson M, Hakansson L, Karawacjzyk M, Peterson C, Seveus L, Trulson A: Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease. Clin Exp Allergy 1999;29:1172–1186.
27.
Nitto T, Dyer KD, Czapiga M, Rosenberg HF: Evolution and function of leukocyte RNase A ribonucleases of the avian species, Gallus gallus. J Biol Chem 2006;281:25622–25634.
28.
Domachowske JB, Dyer KD, Bonville CA, Rosenberg HF: Recombinant human eosinophil-derived neurotoxin/RNase 2 functions as an effective antiviral agent against respiratory syncytial virus. J Infect Dis 1998;177:1458–1464.
29.
Surasombatpattana P, Hamel R, Patramool S, Luplertlop N, Thomas F, Despres P, Briant L, Yssel H, Misse D: Dengue virus replication in infected human keratinocytes leads to activation of antiviral innate immune responses. Infect Genet Evol 2011;11:1664–1673.
30.
Torrent M, Sanchez D, Buzon V, Nogues MV, Cladera J, Boix E: Comparison of the membrane interaction mechanism of two antimicrobial RNases: RNase 3/ECP and RNase 7. Biochim Biophys Acta 2009;1788:1116–1125.
31.
Torrent M, Badia M, Moussaoui M, Sanchez D, Nogues MV, Boix E: Comparison of human RNase 3 and RNase 7 bactericidal action at the gram-negative and gram-positive bacterial cell wall. FEBS J 2010;277:1713–1725.
32.
Lin YM, Wu SJ, Chang TW, Wang CF, Suen CS, Hwang MJ, Chang MD, Chen YT, Liao YD: Outer membrane protein I of Pseudomonas aeruginosa is a target of cationic antimicrobial peptide/protein. J Biol Chem 2010;285:8985–8994.
33.
Spencer JD, Schwaderer AL, Dirosario JD, McHugh KM, McGillivary G, Justice SS, Carpenter AR, Baker PB, Harder J, Hains DS: Ribonuclease 7 is a potent antimicrobial peptide within the human urinary tract. Kidney Int 2011;80:174–180.
34.
Abtin A, Eckhart L, Mildner M, Ghannadan M, Harder J, Schröder JM, Tschachler E: Degradation by stratum corneum proteases prevents endogenous RNase inhibitor from blocking antimicrobial activities of RNase 5 and RNase 7. J Invest Dermatol 2009;129:2193–2201.
35.
Reithmayer K, Meyer KC, Kleditzsch P, Tiede S, Uppalapati SK, Gläser R, Harder J, Schröder JM, Paus R: Human hair follicle epithelium has an antimicrobial defence system that includes the inducible antimicrobial peptide psoriasin (s100a7) and RNase 7. Br J Dermatol 2009;161:78–89.
36.
Simanski M, Dressel S, Gläser R, Harder J: RNase 7 protects healthy skin from Staphylococcus aureus colonization. J Invest Dermatol 2010;130:2836–2838.
37.
Zanger P, Holzer J, Schleucher R, Steffen H, Schittek B, Gabrysch S: Constitutive expression of the antimicrobial peptide RNase 7 is associated with Staphylococcus aureus infection of the skin. J Infect Dis 2009;200:1907–1915.
38.
Mohammed I, Yeung A, Abedin A, Hopkinson A, Dua HS: Signalling pathways involved in ribonuclease-7 expression. Cell Mol Life Sci 2011;68:1941–1952.
39.
Gläser R, Navid F, Schuller W, Jantschitsch C, Harder J, Schröder JM, Schwarz A, Schwarz T: UV-B radiation induces the expression of antimicrobial peptides in human keratinocytes in vitro and in vivo. J Allergy Clin Immunol 2009;123:1117–1123.
40.
Wanke I, Steffen H, Christ C, Krismer B, Gotz F, Peschel A, Schaller M, Schittek B: Skin commensals amplify the innate immune response to pathogens by activation of distinct signaling pathways. J Invest Dermatol 2011;131:382–390.
41.
Eberhard J, Pietschmann R, Falk W, Jepsen S, Dommisch H: The immune response of oral epithelial cells induced by single-species and complex naturally formed biofilms. Oral Microbiol Immunol 2009;24:325–330.
42.
Eberhard J, Menzel N, Dommisch H, Winter J, Jepsen S, Mutters R: The stage of native biofilm formation determines the gene expression of human beta-defensin-2, psoriasin, ribonuclease 7 and inflammatory mediators: a novel approach for stimulation of keratinocytes with in situ formed biofilms. Oral Microbiol Immunol 2008;23:21–28.
43.
Harder J, Dressel S, Wittersheim M, Cordes J, Meyer-Hoffert U, Mrowietz U, Folster-Holst R, Proksch E, Schröder JM, Schwarz T, Gläser R: Enhanced expression and secretion of antimicrobial peptides in atopic dermatitis and after superficial skin injury. J Invest Dermatol 2010;130:1355–1364.
44.
de Jongh GJ, Zeeuwen PL, Kucharekova M, Pfundt R, van der Valk PG, Blokx W, Dogan A, Hiemstra PS, van de Kerkhof PC, Schalkwijk J: High expression levels of keratinocyte antimicrobial proteins in psoriasis compared with atopic dermatitis. J Invest Dermatol 2005;125:1163–1173.
45.
Henseler T, Christophers E: Disease concomitance in psoriasis. J Am Acad Dermatol 1995;32:982–986.
46.
Nomura I, Goleva E, Howell MD, Hamid QA, Ong PY, Hall CF, Darst MA, Gao B, Boguniewicz M, Travers JB, Leung DY: Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol 2003;171:3262–3269.
47.
Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, Gallo RL, Leung DY: Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002;347:1151–1160.
48.
Gambichler T, Skrygan M, Tomi NS, Othlinghaus N, Brockmeyer NH, Altmeyer P, Kreuter A: Differential mRNA expression of antimicrobial peptides and proteins in atopic dermatitis as compared to psoriasis vulgaris and healthy skin. Int Arch Allergy Immunol 2008;147:17–24.
49.
Gao X, Xu Z: Mechanisms of action of angiogenin. Acta Biochim Biophys Sin (Shanghai) 2008;40:619–624.
50.
Fett JW, Strydom DJ, Lobb RR, Alderman EM, Bethune JL, Riordan JF, Vallee BL: Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry 1985;24:5480–5486.
51.
Hooper LV, Stappenbeck TS, Hong CV, Gordon JI: Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat Immunol 2003;4:269–273.
52.
Avdeeva SV, Chernukha MU, Shaginyan IA, Tarantul VZ, Naroditsky BS: Human angiogenin lacks specific antimicrobial activity. Curr Microbiol 2006;53:477–478.
53.
Rendl M, Mayer C, Weninger W, Tschachler E: Topically applied lactic acid increases spontaneous secretion of vascular endothelial growth factor by human reconstructed epidermis. Br J Dermatol 2001;145:3–9.
54.
Zasloff M: Antimicrobial RNases of human skin. J Invest Dermatol 2009;129:2091–2093.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.